Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.
暂无分享,去创建一个
J. Ahn | S. Jeong | N. Ku | J. Choi | J. Kim | Hye Seong | I. Y. Jung | Heun Choi | Jung Ho Kim | Wooyong Jeong
[1] A. Maclean,et al. HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] Hsin-Yun Sun,et al. Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan , 2016, Scientific Reports.
[3] C. Kang,et al. The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[4] Jennifer F Hoy,et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. , 2016, JAMA.
[5] N. Félix,et al. The HIV therapy market , 2016, Nature Reviews Drug Discovery.
[6] M. Poljak,et al. Primary resistance to integrase strand-transfer inhibitors in Europe. , 2015, The Journal of antimicrobial chemotherapy.
[7] M. Wainberg,et al. Integrase strand transfer inhibitors in the management of HIV-positive individuals , 2014, Annals of medicine.
[8] R. Haubrich,et al. Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study , 2014, The Journal of infectious diseases.
[9] Min Hyung Kim,et al. HIV antiretroviral resistance mutations among antiretroviral treatment-naive and -experienced patients in South Korea. , 2013, AIDS research and human retroviruses.
[10] Anne-Mieke Vandamme,et al. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update , 2009, PloS one.